INDIAN JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2023-06-06 as150001 来自黑龙江省

审稿速度:6.0
经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。

164 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2019-04-01 1de11f7fm56(暂无匿称)

3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表:
求好运

188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运

205 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2023-02-11 Doctor小雷来自重庆

偏重的研究方向：肿瘤
经验分享：这个期刊有消息吗

132 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2019-01-31 1de11f7fm56(暂无匿称)

求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表:
6个月收到修改通知

188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知

242 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2019-01-31 1de11f7fm56(暂无匿称)

6个月收到修改通知

209 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2022-12-15 ms9000000075161030 来自广东省

审稿速度:6.0 | 投稿命中率:5.0
经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。

159 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2022-06-07 qq09121044

under process 是外审了没？

119 18 举报

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2022-12-04 Doctor小雷来自重庆

偏重的研究方向：肿瘤
经验分享：如果有投稿状态更新，请兄弟们分享一下

144 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2020-01-30 12464da8m54(暂无昵称)

投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊

199 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2141124, encodeId=ac8c214112492, content=审稿速度:6.0 经验分享：投稿6个月，没任何消息。撤稿信发出去近1个月，没任何消息。感觉此杂志已经死亡。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bb71507338, createdName=as150001, createdTime=Tue Jun 06 19:41:37 CST 2023, time=2023-06-06, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=568940, encodeId=f645568940c7, content=3/31号接受，这个杂志一旦开始审稿了就挺快的，大概3个月188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 求好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Mon Apr 01 00:00:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114133, encodeId=052c21141334b, content=偏重的研究方向：肿瘤 经验分享：这个期刊有消息吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sat Feb 11 17:20:01 CST 2023, time=2023-02-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=566379, encodeId=53265663e904, content=求好运188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, beContent=188****3656(暂无匿称) 2019-01-31 00:00:00 发表: 6个月收到修改通知, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566378, encodeId=d03f5663e8ce, content=6个月收到修改通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Thu Jan 31 00:00:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106251, encodeId=cc94210625146, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：投了五个月了还没审，退稿好几天也没消息，发邮件显示地址不存在。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1da56415723, createdName=ms9000000075161030, createdTime=Thu Dec 15 21:45:08 CST 2022, time=2022-12-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1224937, encodeId=f5bd122493e0b, content=under process 是外审了没？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3381607951, createdName=qq09121044, createdTime=Tue Jun 07 11:37:21 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104309, encodeId=e7f62104309f4, content=偏重的研究方向：肿瘤 经验分享：如果有投稿状态更新，请兄弟们分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Dec 04 21:13:50 CST 2022, time=2022-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=583981, encodeId=99ba58398114, content=投一个多月了，还没告诉我有没有送外审阿，拒绝就干脆点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Thu Jan 30 00:00:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916669, encodeId=557391666921, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da655165444, createdName=146c6496m33(暂无昵称), createdTime=Thu Jan 14 22:42:27 CST 2021, time=2021-01-14, status=1, ipAttribution=)]

2021-01-14 146c6496m33(暂无昵称)

审稿速度:2.0 | 投稿命中率:50.0
经验分享：审稿较快，但是见刊非常慢，我的2020-04接收的，2020-12才在官网上ahead of print

2 6 举报

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务